Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Affinity Asset Advisors, Llc > Profile

Instuitional Investor - Affinity Asset Advisors, Llc

Fund Profile
Filing Period:
Fund Name: Affinity Asset Advisors, Llc
Portfolio Value $547,527,586
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Immunogen Inc.
 IMGN 1,404,608 $41,646,627 7.6%
2.
Cerevel Therapeutics Holdings Inc.
 CERE 750,000 $31,800,000 5.8%
3.
Cymabay Therapeutics Inc.
 CBAY 1,090,441 $25,756,216 4.7%
4.
Madrigal Pharmaceuticals Inc.
 100,000 $23,138,000 4.22%
5.
Xenon Pharmaceuticals Inc.
 XENE 460,000 $21,187,600 3.86%
Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)